Abstract
Aim To find out, best measures for the prevention of jaundice in pregnancy.
Settings A large public tertiary referral Centre for Obstetric care in Chennai Metropolis. Materials and Methods Case records of all antenatal mothers with jaundice in any trimester of pregnancy attending the hospital over a period of 1 year, were analysed to find out best measures for early detection and prevention of jaundice in pregnancy.
Results There were a total number of 17,890 antenatal admissions during the study period and 51 pregnant women with jaundice were admitted for treatment. The incidence of jaundice complicating pregnancy during this period in our hospital was 0.29%. Nearly, 74% of the jaundiced patients were between 20 and 29 years. About 92.1% of women belonged to class 4 and 5. The maximum percentage of (54.9%) jaundiced women were primigravida. Most women (80.39%) were presented with jaundice during the third trimester. Predominant symptoms were discoloration of skin present in all, and nausea and vomiting in 70.6% of women. At least 95% of women were ignorant about drinking water hygiene and use of safe water.
Viral hepatitis was the commonest etiology in 50.98% of women in the study. HELLP syndrome, a life-threatening pregnancy complication, was diagnosed as a cause of jaundice in 30.72%. Acute fatty liver of pregnancy was causative for 50% of deaths. HELLP syndrome was fatal in one unbooked pregnant woman. Preterm births were seen in 46% of women. Perinatal mortality was 33% and of these 30% was due to prematurity. AFLP and chronic liver disease with portal hypertension were the cause in 7.84%. Maternal mortality among pregnant women with jaundice was a significantly high 7.8%,
and accounted for 12.5% of total maternal deaths (P < 0. 0000001).
Conclusion Although liver diseases are seen infrequently in pregnancy, the complications associated with liver dysfunction can result in severe maternal and fetal compromise. Obstetricians must remain vigilant to detect early compromise in liver function to save mother and baby. Health workers should be trained in screening and early referral. Safe drinking water should be provided for all. Improved sanitary precautions should be taught during antenatal visits and hazards of promiscuity with relation to hepatitis B and other infections should be explained to the public. Screening for hepatitis B should be done during the first visit, especially in high-risk areas for liver infections. Detection of infections such as hepatitis E, and leptospirosis in pregnant women is life saving for mother and baby if done early. The call is for early booking of pregnant women to prevent maternal and perinatal morbidity and mortality. Appropriate management of preeclampsia by early diagnosis and referral for high-risk pregnancies.
Keywords
References
Kondareddy T, Krithika KA. Jaundice in pregnancy–a clinical study at JSS Hospital. Int J Reprod Contracept Obstet Gynaecol.2016;5:2257–2260.
Morthala Greeshma Reddy, G.C. Prabhakar, Vijayasree. Maternal and fetal outcome in Jaundice complicating pregnancy. Journal of NTR institute of medical sciences. March 5 - 2017.
Nagaria tripti, Agarwal Sarita. Fetomaternal outcome in jaundice during pregnancy. J Obstet Gynecol India. 2005;55:424–427.
Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994;170:1418–1423.
Marchioni Beery RM, Vaziri H, Forouhar F. Primary biliary cirrhosis and primary sclerosing cholangitis: a review featuring a a women’s health perspective. J Clin Transl Hepatol. 2014;2:266–284.
Karegoudar D, Dhirubhai PR, Dhitai M, Amgain K. A study of liver disorder and its consequences in pregnant women with jaundice in tertiary care centre in Belgaum, Karnataka, India. IOSR J Dent Med Sci. 2014;13:14–18.
Yong to Han, Chao Sun, Cia Xia Liu. Clinical features and outcome of hepatitis B in pregnancy. BMC, Infect Dis. 2014;14:368.
Sahai S, Kiran R. Acute liver failure in pregnancy: causative and prognostic factors. Saudi J GE. 2015;21:30–34.
Lata I. Hepatobiliary disease during pregnancy and their management: an update. Int J Crit Illn Inj Sci. 2013;3:175–182.
Solanke D, Rathi C, Pandey V, Patil M, Phadke A, Sawant P. Etiology, clinical profile, and outcome of liver disease in pregnancy with predictors of maternal mortality: A prospective study from Western India. Indian J Gastroenterol. 2016;35:450–458.
Shinde N, Patil T, Deshpande A, Gulhane R, Patil M, Bansod Y. Clinical profile, maternal and fetal outcomes of
acute hepatitis e in pregnancy. Ann Med Health Sci Res.2014;4:S133–S139.
Gurley ES, Hossain MJ, Paul RC, Sazzad HM, Islam MS, Parveen S, et al. Outbreak of hepatitis E in urban Bangladesh resulting in maternal and perinatal mortality. Clin Infect Dis. 2014;59:658–665.
Kong X, Kong Y, Zhang F, Wang T, Yan J. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy. Medicine (Baltimore). 2016;95:e4949.
Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology.2012;142:773–781.e2.
Elinav E, Ben-Dov IZ, Shapira Y, Daudi N, Adler R, Shouval D. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology. 2006;130:1129–1134.
Gurung V, Williamson C, Chappell L, Chambers J, Briley A, Broughton Pipkin F, et al. Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis. BMC Preg Childbirth. 2009;9:19.
Duraiswamy S, Sheffield JS, Mcintire D, Leveno K, Mayo MJ. Updated etiology and significance of elevated bilirubin during pregnancy: changes parallel shift in demographics and vaccination status. Dig Dis Sci. 2017;62:517–525.
Liu G, Shang X, Yuan B, Han C, Wang Y. Acute fatty liver of pregnancy: analysis on the diagnosis and treatment of 15 cases. J Reprod Med. 2016;61:282–286.
Joutsiniemi T, Timonen S, Linden M, Suvitie P, Ekblad U. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid. BMC Gastroenterol. 2015;15:92.
Refbacks
- There are currently no refbacks.
Copyright (c) 2017 Journal of Pharmaceutical and Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.